XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

80 hedge funds and large institutions have $308M invested in Xenon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 5 closing their positions.

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
16
Reduced
27
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.1M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$27.1M
3
SCM
3
Soleus Capital Management
Connecticut
$5.54M
4
GIM
4
Granahan Investment Management
Massachusetts
$1.76M
5
Goldman Sachs
5
Goldman Sachs
New York
$686K

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$3.32M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$4.95M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$10M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$5.15M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
76
Citigroup
New York
$3K -$47.7K -4,647 -94%
Millennium Management
77
Millennium Management
New York
$1.32K -$544 -49,151 -29%
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$1.05K +$1.05K +95 New
JPMorgan Chase & Co
79
JPMorgan Chase & Co
New York
– -$1.21M -96,372 Closed
Squarepoint
80
Squarepoint
New York
– -$305K -24,321 Closed
ECM
81
ExodusPoint Capital Management
New York
– -$249K -19,888 Closed
DWA
82
Dorsey Wright & Associates
California
– -$9K -674 Closed
Simplex Trading
83
Simplex Trading
Illinois
– -$1K -126 Closed
1 2 3
4